Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting

Summary: Background: Diarrhoea, a global cause of child mortality and morbidity, is linked to adverse consequences including childhood stunting and death from other diseases. Few studies explore how diarrhoeal mortality varies subnationally, especially by cause, which is important for targeting inv...

Full description

Bibliographic Details
Main Authors: Karoun H Bagamian, PhD, John D Anderson, IV, PhD, Farzana Muhib, MPH, Oliver Cumming, MSc, Lindsey A Laytner, PhD, Thomas F Wierzba, ProfPhD, Richard Rheingans, ProfPhD
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X19304565
_version_ 1818291026146623488
author Karoun H Bagamian, PhD
John D Anderson, IV, PhD
Farzana Muhib, MPH
Oliver Cumming, MSc
Lindsey A Laytner, PhD
Thomas F Wierzba, ProfPhD
Richard Rheingans, ProfPhD
author_facet Karoun H Bagamian, PhD
John D Anderson, IV, PhD
Farzana Muhib, MPH
Oliver Cumming, MSc
Lindsey A Laytner, PhD
Thomas F Wierzba, ProfPhD
Richard Rheingans, ProfPhD
author_sort Karoun H Bagamian, PhD
collection DOAJ
description Summary: Background: Diarrhoea, a global cause of child mortality and morbidity, is linked to adverse consequences including childhood stunting and death from other diseases. Few studies explore how diarrhoeal mortality varies subnationally, especially by cause, which is important for targeting investments. Even fewer examine indirect effects of diarrhoeal morbidity on child mortality. We estimated the subnational distribution of mortality, morbidity, and childhood stunting attributable to enterotoxigenic Escherichia coli (ETEC) and shigella infection in children younger than 5 years from 11 eastern and central African countries. These pathogens are leading causes of diarrhoea in young children and have been linked to increased childhood stunting. Methods: We combined proxy indicators of morbidity and mortality risk from the most recent Demographic and Health Surveys with published relative risks to estimate the potential distribution of diarrhoeal disease risk. To estimate subnational burden, we used country-specific or WHO region-specific morbidity and mortality estimates and distributed them subnationally by three indices that integrate relevant individual characteristics (ie, underweight, probability of receiving oral rehydration treatment of diarrhoea, and receiving vitamin A supplementation) and household characteristics (ie, type of drinking water and sanitation facilities). Findings: Characterising ETEC and shigella subnational estimates of indirect morbidity (infection-attributable stunting) and indirect mortality (stunting-related deaths from other infectious diseases) identified high-risk areas that could be missed by traditional metrics. Burundi and Democratic Republic of the Congo had the highest ETEC-associated and shigella-associated mortality and stunting rates. Mozambique, Democratic Republic of the Congo, and Zimbabwe had the greatest subnational heterogeneity in most ETEC and shigella mortality measures. Inclusion of indirect ETEC and shigella mortality in burden estimates resulted in a 20–30% increase in total ETEC and shigella mortality rates in some subnational areas. Interpretation: Understanding the indirect mortality and morbidity of diarrhoeal pathogens on a subnational level will strengthen disease control strategies and could have important implications for the relative impact and cost-effectiveness of new enteric vaccines. Because our methods rely on publicly available data, they could be employed for national planning. Funding: Bill & Melinda Gates Foundation.
first_indexed 2024-12-13T02:37:31Z
format Article
id doaj.art-f72cd5d187394f0a83050b0efe013c53
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-13T02:37:31Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-f72cd5d187394f0a83050b0efe013c532022-12-22T00:02:23ZengElsevierThe Lancet Global Health2214-109X2020-01-0181e101e112Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stuntingKaroun H Bagamian, PhD0John D Anderson, IV, PhD1Farzana Muhib, MPH2Oliver Cumming, MSc3Lindsey A Laytner, PhD4Thomas F Wierzba, ProfPhD5Richard Rheingans, ProfPhD6Department of Environmental & Global Health, University of Florida, FL, USA; Bagamian Scientific Consulting, Gainesville, FL, USA; Correspondence to: Karoun H Bagamian, Bagamian Scientific Consulting, Gainesville, FL 32601, USADepartment of Environmental & Global Health, University of Florida, FL, USA; Goodnight Family Department of Sustainable Development, Appalachian State University, Boone, NC, USAPATH, Washington, DC, USADepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UKDepartment of Environmental & Global Health, University of Florida, FL, USAPATH, Washington, DC, USA; Department of Internal Medicine, Section on Infectious Diseases, Wake Forest School of Medicine, Winston Salem, NC, USAGoodnight Family Department of Sustainable Development, Appalachian State University, Boone, NC, USASummary: Background: Diarrhoea, a global cause of child mortality and morbidity, is linked to adverse consequences including childhood stunting and death from other diseases. Few studies explore how diarrhoeal mortality varies subnationally, especially by cause, which is important for targeting investments. Even fewer examine indirect effects of diarrhoeal morbidity on child mortality. We estimated the subnational distribution of mortality, morbidity, and childhood stunting attributable to enterotoxigenic Escherichia coli (ETEC) and shigella infection in children younger than 5 years from 11 eastern and central African countries. These pathogens are leading causes of diarrhoea in young children and have been linked to increased childhood stunting. Methods: We combined proxy indicators of morbidity and mortality risk from the most recent Demographic and Health Surveys with published relative risks to estimate the potential distribution of diarrhoeal disease risk. To estimate subnational burden, we used country-specific or WHO region-specific morbidity and mortality estimates and distributed them subnationally by three indices that integrate relevant individual characteristics (ie, underweight, probability of receiving oral rehydration treatment of diarrhoea, and receiving vitamin A supplementation) and household characteristics (ie, type of drinking water and sanitation facilities). Findings: Characterising ETEC and shigella subnational estimates of indirect morbidity (infection-attributable stunting) and indirect mortality (stunting-related deaths from other infectious diseases) identified high-risk areas that could be missed by traditional metrics. Burundi and Democratic Republic of the Congo had the highest ETEC-associated and shigella-associated mortality and stunting rates. Mozambique, Democratic Republic of the Congo, and Zimbabwe had the greatest subnational heterogeneity in most ETEC and shigella mortality measures. Inclusion of indirect ETEC and shigella mortality in burden estimates resulted in a 20–30% increase in total ETEC and shigella mortality rates in some subnational areas. Interpretation: Understanding the indirect mortality and morbidity of diarrhoeal pathogens on a subnational level will strengthen disease control strategies and could have important implications for the relative impact and cost-effectiveness of new enteric vaccines. Because our methods rely on publicly available data, they could be employed for national planning. Funding: Bill & Melinda Gates Foundation.http://www.sciencedirect.com/science/article/pii/S2214109X19304565
spellingShingle Karoun H Bagamian, PhD
John D Anderson, IV, PhD
Farzana Muhib, MPH
Oliver Cumming, MSc
Lindsey A Laytner, PhD
Thomas F Wierzba, ProfPhD
Richard Rheingans, ProfPhD
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
The Lancet Global Health
title Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
title_full Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
title_fullStr Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
title_full_unstemmed Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
title_short Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
title_sort heterogeneity in enterotoxigenic escherichia coli and shigella infections in children under 5 years of age from 11 african countries a subnational approach quantifying risk mortality morbidity and stunting
url http://www.sciencedirect.com/science/article/pii/S2214109X19304565
work_keys_str_mv AT karounhbagamianphd heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT johndandersonivphd heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT farzanamuhibmph heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT olivercummingmsc heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT lindseyalaytnerphd heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT thomasfwierzbaprofphd heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting
AT richardrheingansprofphd heterogeneityinenterotoxigenicescherichiacoliandshigellainfectionsinchildrenunder5yearsofagefrom11africancountriesasubnationalapproachquantifyingriskmortalitymorbidityandstunting